These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3970836)

  • 21. Hepatotoxic reactions in a patient treated with etretinate.
    Weiss VC; West DP; Ackerman R; Robinson LA
    Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C
    Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic active hepatitis associated with etretinate therapy.
    Weiss VC; Layden T; Spinowitz A; Buys CM; Nemchausky BA; West DP; Emmons KM
    Br J Dermatol; 1985 May; 112(5):591-7. PubMed ID: 4005158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etretinate (Tigason) hepatitis in 2 patients.
    van Voorst Vader PC; Houthoff HJ; Eggink HF; Gips CH
    Dermatologica; 1984; 168(1):41-6. PubMed ID: 6698264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of psoriatic rheumatism with a retinoid derivative: etretinate. Open preliminary trial on 12 patients reviewed after 6 months].
    Rampon S; Fraysse MP; Ristori JM; Sauvezie B; Bussière JL; Souteyrand P
    Rev Rhum Mal Osteoartic; 1985 Feb; 52(2):127-31. PubMed ID: 3872473
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis.
    Parker S; Coburn P; Lawrence C; Marks J; Shuster S
    Br J Dermatol; 1984 Feb; 110(2):215-20. PubMed ID: 6365147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jul; 26(1):9-43. PubMed ID: 6224672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of etretinate in psoriatic arthritis.
    Klinkhoff AV; Gertner E; Chalmers A; Gladman DD; Stewart WD; Schachter GD; Schachter RK
    J Rheumatol; 1989 Jun; 16(6):789-91. PubMed ID: 2778761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis.
    Brechtel B; Wellenreuther U; Toppe E; Czarnetzki BM
    J Am Acad Dermatol; 1994 Jun; 30(6):1023-4. PubMed ID: 8188867
    [No Abstract]   [Full Text] [Related]  

  • 30. Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy.
    Lowe NJ; Borok ME; Ashley JM; Alfin-Slater RB
    Arch Dermatol; 1988 Feb; 124(2):177-8. PubMed ID: 3341796
    [No Abstract]   [Full Text] [Related]  

  • 31. Etretinate in pustular psoriasis of palms and soles.
    White SI; Marks JM; Shuster S
    Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombocytopenia associated with etretinate therapy.
    Liang R
    Acta Haematol; 1988; 79(2):112-3. PubMed ID: 3124469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML; Bazzichi L; Marotta G; Pasero G
    Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased muscle tone during etretinate therapy.
    Ellis CN; Gilbert M; Cohen KA; Albers JW; Ball RD; Albin RL; Silverman A; Voorhees JJ
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):907-9. PubMed ID: 3711400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etretinate and psoriasis.
    Morison WL
    Arch Dermatol; 1987 Jul; 123(7):879-81. PubMed ID: 3606164
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral neuropathy during etretinate therapy for psoriasis.
    Hammer CJ; Carter CC; Hanifin JM
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):272-3. PubMed ID: 8381828
    [No Abstract]   [Full Text] [Related]  

  • 39. Etretinate and visual function: a 1-year follow-up study.
    Pitts JF; Mackie RM; Dutton GN; McClure EA; Allan D
    Br J Dermatol; 1991 Jul; 125(1):53-5. PubMed ID: 1873203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etretinate therapy reduces inpatient treatment of psoriasis.
    Ellis CN; Hermann RC; Gorsulowsky DC; Goldfarb MT; Voorhees JJ
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):787-91. PubMed ID: 3680657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.